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Abstract
Background: Acute RT-induced damage to the lung is characterized by inflammatory changes,
which proceed to the development of fibrotic lesions in the late phase of injury. Ultimately,
complete structural ablation will ensue, if the source of inflammatory / fibrogenic mediators and
oxidative stress is not removed or attenuated. Therefore, the purpose of this study is to determine
whether overexpression of extracellular superoxide dismutase (EC-SOD) in mice ameliorates
acute radiation induced injury by inhibiting activation of TGFβ 1 and downregulating the Smad 3 arm
of its signal transduction pathway.
Methods: Whole thorax radiation (single dose, 15 Gy) was delivered to EC-SOD overexpressing
transgenic (XRT-TG) and wild-type (XRT-WT) animals. Mice were sacrificed at 1 day, 1 week, 3,
6, 10 and 14 weeks. Breathing rates, right lung weights, total/differential leukocyte count, activated
TGFβ 1 and components of its signal transduction pathway (Smad 3 and p-Smad 2/3) were assessed
to determine lung injury.
Results: Irradiated wild-type (XRT-WT) animals exhibited time dependent increase in breathing
rates and right lung weights, whereas these parameters were significantly less increased (p < 0.05)
at 3, 6, 10 and 14 weeks in irradiated transgenic (XRT-TG) mice. An inflammatory response
characterized predominantly by macrophage infiltration was pronounced in XRT-WT mice. This
acute inflammation was significantly attenuated (p < 0.05) in XRT-TG animals at 1, 3, 6 and 14
weeks. Expression of activated TGFβ 1 and components of its signal transduction pathway were
significantly reduced (p < 0.05) at later time-points in XRT-TG vs. XRT-WT.
Conclusion: This study shows that overexpression of EC-SOD confers protection against RT-
induced acute lung injury. EC-SOD appears to work, in part, via an attenuation of the macrophage
response and also decreases TGFβ 1 activation with a subsequent downregulation of the profibrotic
TGFβ  pathway.
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Background
Acute radiation (RT) induced lung toxicity and subse-
quently occurring pulmonary fibrosis are considered to be
critical, dose-limiting factors for radiation therapy of tho-
racic malignancies [1]. Subclinical molecular and cellular
events commence during RT therapy, but the clinical fea-
tures and histological findings may not be revealed for
months, or even years after the treatment [2].
In RT-induced lung injury, damage to endothelial and epi-
thelial cells are thought to be the initial steps leading to
acute lung toxicity [3]. Tissue damage and repair initiated
by irradiation is associated with the production of impor-
tant biological mediators, such as cytokines [4]. These
cytokines perpetuate the inflammatory and fibrogenic
processes associated with RT injury [5]. The relative role of
cytokine dysregulation versus direct tissue injury from
irradiation in the pathogenesis of acute and late toxicities
is not well defined. Previous observations and recent
advancements in understanding the role of these
cytokines implicate transforming growth factor-β 1 (TGF-
β ) as a key component in the development of RT-induced
normal tissue injury in multiple organs, including lungs
[6].
In addition to cytokine dysregulation, an oxidant/antioxi-
dant imbalance in the lower respiratory tract has been
proposed as the mechanism of lung injury in a number of
inflammatory lung conditions [7,8]. Ionizing RT is associ-
ated with increased production of free radicals [9], which
is reflected by the accumulation of oxidatively damaged
cellular macromolecules. RT may impair lung cells either
directly via generation of reactive oxygen species (ROS)
[9] or indirectly via the action on parenchymal and
inflammatory cells through biological mediators [4,5].
This process may subordinate the cellular antioxidant
defenses and lead to the accumulation of toxic levels of
ROS.
Extracellular superoxide dismutase (EC-SOD), one of the
subtypes of naturally occurring superoxide dismutases, is
the dominant antioxidant enzyme found in a variety of
extracellular compartments [10]. These enzymes act by
catalyzing the dismutation of the superoxide anion radi-
cal to oxygen and hydrogen peroxide. EC-SOD is secreted
into the extracellular spaces, and in the lung it is expressed
primarily by the alveolar type II pneumocytes [11]. EC-
SOD is mainly bound to the extracellular matrix but it is
also detectable in plasma [12]. The protective role of this
enzyme has been studied in RT, bleomycin or hyperoxia
induced oxidative stress lung injury [13-15].
Recently, we have reported that overexpression of EC-
SOD in transgenic mice appears to protect against RT-
induced chronic injury [13]. In the present study, we ana-
lyzed the early events at the molecular and cellular levels
to clarify the mechanisms by which overexpression of EC-
SOD protects against RT-induced lung damage. We
hypothesized that continuous over-production of ROS,
during and well after radiotherapy has been completed, is
responsible for the pathogenesis of RT-induced lung
injury and that continuous overexpression of EC-SOD
would ameliorate this injury.
Methods
Animals
Transgenic (TG) B6C3 mice that overexpress human EC-
SOD (hEc-SOD) in alveolar and airway epithelial cells
and wild-type (WT) littermates were utilized for this
study. The generation of the TG mice has been described
in detail by Folz et. al. [15]. These mice are maintained in
a B6C3 background. Heterozygous transgenic positive
mice are always bred to an F1 (C57BL/6 × C3H) mouse,
and the transgenic positive pups are compared to their
transgenic negative littermates. Polymerase chain reaction
(PCR) analysis of tail DNA was performed to confirm the
genotype status. PCR positive and negative animals were
used for all these studies. The animals were maintained in
cages at room temperature, with a 12 hr light-dark cycle
with access to food and water ad libitum. The protocol was
approved by the Duke University Medical Center Institu-
tional Animal Care and Use Committee.
Thoracic irradiation
The animals were randomly distributed into four groups;
unirradiated, wild-type (Con -WT), EC-SOD overexpress-
ing transgenic (Con -TG), irradiated EC-SOD overexpress-
ing transgenic (XRT-TG) and wild-type mice (XRT-WT).
RT was delivered with a single dorsal-ventral field using 4-
MV photons, for a dose of 15 Gy to the whole thorax with
0.5 cm bolus material. Mice were sacrificed at six different
time points post irradiation (1 day, 1, 3, 6, 10 and 14
wks), along with matched controls.
Breathing frequency
Functional assessment of lung damage was performed
weekly, by measuring breathing frequency, using a whole-
body plethysmography chamber (Model RM-80; Colum-
bus Instruments, Columbus, Ohio). Four readings were
taken at each time point for every animal, and the mean
value was used for analysis.
Broncho-alveolar lavage fluid
Mice were anesthetized by intraperitoneal injection of
pentobarbital (50 µg/g). After the onset of adequate
anesthesia, the trachea was exposed and a 20-gauge nee-
dle was used to puncture the trachea, which was replaced
with a 21-gauge blunt needle. A silk ligature was fastened
around the trachea to secure the needle. Bronchoalveolar
lavage (BAL) was performed with 1 ml PBS using a 1-mlBMC Cancer 2005, 5:59 http://www.biomedcentral.com/1471-2407/5/59
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syringe and repeated once. The collected fluid was imme-
diately processed as follows. BAL fluid (300 µL) was cyto-
centrifuged and stained with a leukostat stain kit (Fisher
Scientific Co., Pittsburgh, Pennsylvania, USA). A mini-
mum of 300 cells were subsequently counted to obtain a
differential cell count. Cellular BALF (30–50 µL) was
stained with trypan blue, and the total cell count was
manually obtained using a Neubauer hemocytometer
(Reichert, Buffalo, New York, USA). The remaining BALF
was centrifuged at 1,800 g for 5 minutes at 4°C, and the
supernatant was decanted and centrifuged a second time
at 12,000 g for 10 minutes at 4°C. The supernatant was
collected and saved at -80°C for further analysis, and the
pelleted cells were snap frozen in liquid nitrogen and
stored at -80°C.
Wet lung weights
At the time of sacrifice, the right lung was removed, gently
blotted, and the wet weight recorded. The right lung was
snap frozen in liquid nitrogen and then stored in -80°C
freezer.
Histopathology
The left lungs from mice in each group and at each time
point were fixed in situ for microscopy by intratracheal
instillation of 4% paraformaldehyde in PBS at 20 cm H2O
pressure for 10 minutes and subsequently removed from
the thorax and immersed in additional fixative for 4–6
hours. These tissues were paraffin-embedded, sectioned,
and stained with hematoxylin and eosin. Histopathologic
evidence for lung injury was scored on a scale from 0 (nor-
mal) to 4 (most severe) as described earlier [16]. Parame-
ters assessed were the degree of vascular congestion,
thickening of alveolar wall (edema), hyaline membrane
formation in the distal airway, and inflammatory cell
accumulation.
Tissue TGF-β 1 activity
Frozen lung tissue was thawed at room temperature, then
placed in 1X phosphate buffered saline (PBS) with 0.5
mM EDTA according to weight (10 µL of buffer per 1 mg
of tissue). The sample was homegenized by sonication,
then spun at 15,000 rpm for 30 minutes at 4°C. The
supernatant was used for the sandwich enzyme-linked
immunosorbent assay (ELISA) in order to quantify the
TGF-β 1. To measure the active TGF-β 1, anti-TGF-β 1 mon-
oclonal antibody and biotinylated anti-TGF-β 1 antibod-
ies were used as the capture and probe antibodies,
respectively. Horseradish peroxidase-conjugated with
streptavidin was used to bind the biotin, followed by sub-
strate reagent and stop solution (all products are from
R&D Systems Inc, Minneapolis, MN). To quantify the
total TGF-β 1, latent TGF-β 1 was activated by adding 0.1
ml 2.5 N Acid / 10 M Urea into 0.1 ml sample and neu-
tralized by adding 0.1 ml 2.7 N NaOH / 1 M Hepes.
Ninety-six-well microtiter plates were read at OD 450 nm
using a kinetic microplate reader (v-max; Molecular
Devices, Menlo Park, CA). The level of TGF-β 1 (total and
active) was determined by comparing the peroxidase
activity to known concentrations of purified TGF-β 1
(R&D Systems Inc, Minneapolis, MN).
Immunohistochemistry (Smad3 And p-Smad2/3)
Immunohistochemistry was carried out as previously
described [17]. Briefly, paraffin embedded tissues were
sectioned at 5 µm thickness, and deparaffinized and
hydrated using a xylene solution and graded ethanol. An
endogenous peroxide blocking solution of 3% hydrogen
peroxide was applied for 20 minutes at room temperature
then rinsed in deionized water. Sections were then placed
in an antigen retrieval solution of citrate buffer from Bio-
genex (San Ramon, CA). The solution was heated in a
microwave for 3–4 minutes, cooled for 2–3 minutes, then
heated again in a microwave. After cooling at room tem-
perature for 20 minutes, sections were rinsed in deionized
water. Next, the sections were incubated in 10% donkey
serum in phosphate-buffered saline (PBS) for 25 minutes
at room temperature to reduce non-specific binding of
antibody. Sections were then rinsed three times with 1X
PBS, covered with primary antibodies against the Smad 3
and p-Smad 2/3 (dilution 1:200, Santa Cruz Biotechnol-
ogy), incubated in a humidity chamber at 37°C for 60
minutes. After rinsing three times with 1% PBS, secondary
and tertiary antibodies were added to the sections per
manufacturer instructions (314KLD, Innovex, Richmond,
CA), with incubation in the humidity chamber at 37°C
for 30 minutes. Sections were again rinsed three times in
1% PBS, then incubated for 2 minutes at room tempera-
ture in a peroxidase substrate solution with 3, 3'-diami-
nobenzidine tetrahydrochloride (Sigma, St. Louis, MO).
The slides were washed three times for 10 minutes in
deionized water, and counterstained with hematoxylin.
After rinsing again with deionized water, sections were
dehydrated in graded ethanol and xylene, then mounted.
Normal serum was used as controls with each set of stains.
Scoring of positive cells
The lung specimens were subjected to blinded evaluation.
After scanning the whole lung section and calculating the
extent of damaged lung parenchyma, 4 representative
fields (40X objective) were selected and analyzed. After
initial qualitative assessment of morphologic changes,
cells that showed staining after RT exposure to the Smad-
3 and p-Smad-2/3 antibodies were recorded. The sum of
the measurement from the 4 fields was totaled, and the
arithmetic mean was calculated. Positive cell counts were
expressed as the average number of cells per field. Means
from lungs of irradiated animals were compared with the
corresponding values obtained from control animals.BMC Cancer 2005, 5:59 http://www.biomedcentral.com/1471-2407/5/59
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Statistical methods
The Student's t test and One-way ANOVA was used to test
the significance of any differences between groups at each
time. A p-value ≤  0.05 was considered statistically signifi-
cant. All datas are presented as mean values (± 95% con-
fidence interval).
Results
Breathing frequency
The pulmonary function of the animals was assessed by
monitoring the respiratory rate every week for 14 weeks.
The XRT-WT mice exhibited a progressive increase in
breathing rates after irradiation beginning at 3 weeks in
comparison to control animals (Figure 1). XRT-TG ani-
mals have a delay in the onset of the functional lung dam-
age (3 weeks), with the significant decrease (p < 0.05) in
respiratory rate as compared to XRT-WT mice. During the
follow-up period of 14 weeks the mean breathing rates of
the two control groups were not changed from baseline
values (249 ± 2.5 vs. 251 ± 2).
Right lung wet weights
The amount of acute lung damage elicited by RT was
measured by an increase in right lung wet weights, which
Comparison of breathing frequency over time Figure 1
Comparison of breathing frequency over time. Changes in breathing rate after 15 Gy of single dose of irradiation to whole 
thorax in XRT-WT and XRT-TG groups. XRT-WT group showed a significant increase in respiratory rate vs. XRT-TG, at 3, 6, 
10 and 14 wks, * p < 0.05. Error bars represent 95% confidence intervals.
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are an index of pulmonary edema and consolidation. RT
treatment resulted in a significant increase in right lung
wet weights in the XRT-WT group (Figure 2). The XRT-TG
mouse strain showed significantly less (p < 0.05) increase
in wet weight from 3 week to 14 weeks, when compared
with their XRT-WT littermates.
Broncho-alveolar lavage fluid cell counts
There was no difference in total cell counts between XRT-
WT and XRT-TG mice 1 day after irradiation (Figure 3a).
However, the total cell count increased significantly by 1
week in the XRT-WT mice when compared with the XRT-
TG mice and remained elevated till 14 weeks (p < 0.05).
Comparison of right lung wet weights over time Figure 2
Comparison of right lung wet weights over time. Lung weights at 1 day, 1,3, 6, 10 and 14 weeks of exposure to radiation. A 
significant increase in the wet weight of XRT-WT lungs was observed by 3 wks of radiation exposure (XRT-WT vs. XRT-TG, 
at 3, 6, 10 and14 wks, * p < 0.05). Error bars represent 95% confidence intervals.
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The increase in BALF cell count was mainly due to an
increase in the number of macrophages (Figure 3b).
Beginning at 1 week, the XRT-WT mice showed a
significantly greater increase in macrophages, which per-
sisted throughout the period of observation (XRT-WT vs.
XRT-TG, at 1, 3, 10, and 14 weeks, p < 0.05).
The lymphocyte count was also significantly increased in
XRT-WT animals beginning at 3 weeks (Figure 3c) as com-
pared to the XRT-TG animals (XRT-WT vs. XRT-TG, at 3
and 10 weeks, p < 0.05).
Histopathology
At 3 weeks after irradiation, the H & E stained lung sec-
tions of XRT-WT mice showed evidence for decreased pul-
monary compliance, as indicated by increased edema,
thickening of the alveolar walls, vascular and interstitial
congestion, and diffuse inflammatory cell infiltration,
which worsened with time (Figure. 4C, E). Histological
changes were also observed in XRT-TG mice after 3 weeks
(Figure. 4D); however they were lesser in degree and
sparse in distribution compared to the XRT-WT animals
(Figure. 4C). In the later time points, the extent and sever-
ity of injury was greater in XRT-WT groups compared to
their XRT-TG animals (Figure 4E, F).
TGFβ  activity
The results of the quantitative assessment of levels of
active and total TGFβ 1 protein expression in lung tissue
are shown in Figure 5. Unirradiated lung tissue of control
animals expressed lower levels of TGFβ 1. Following tho-
racic irradiation, lung tissue levels of active TGFβ 1 in XRT-
WT were increased within the first week. The active TGFβ 1
levels were significantly increased from 6 weeks onward.
The XRT-TG animals demonstrated significantly less
TGFβ 1 activation as compared to XRT-WT mice (XRT-WT
vs. XRT-TG, at 6, 10, and 14 weeks, p < 0.05, Figure 5).
Signal transduction
Increased immunoreactivity for Smad 3 in lung paren-
chyma of XRT-WT animals was noticeable at 1 week, and
Figure 3
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Comparison of cell counts in bronchoalveolar lavage fluid  (BALF) Figure 3
Comparison of cell counts in bronchoalveolar lavage fluid (BALF) 
from XRT-WT and XRT-TG mice exposed to radiation. (a) 
Total cell counts. and (b) Macrophage cell counts at 1day, 
1,3, 6, 10 and 14 weeks of exposure to radiation. Both total 
cell and macrophage counts significantly increased (* p < 
0.05) with time of exposure in XRT-WT animals (c) Lym-
phocyte cells count was significantly increased by 3 wk, in the 
BALF of the XRT-WT group as compared to the XRT-TG 
mice (XRT-WT vs. XRT-TG, at 3, and 10 wks, * p < 0.05). 
Error bars represent 95% confidence intervals.BMC Cancer 2005, 5:59 http://www.biomedcentral.com/1471-2407/5/59
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Light microscopy of hematoxylin and eosin-stained section Figure 4
Light microscopy of hematoxylin and eosin-stained section of representative lungs from controls (A, B ) and treatment groups 
(XRT-WT vs. XRT-TG) at 3 wk (C, D ) and 14 wks (E, F ). Representative lung sections from XRT-WT exposed to 3 wk of 
radiation showing mild to moderate damage at 3 wk after radiation (C ), which gradually increased with time course of injury 
and become moderate to severe with increased thickening of alveolar wall and enhanced infiltration composed mainly of mac-
rophages and other inflammatory cells at 14 weeks (E ). Whereas the XRT-TG mice showing mild-modest alveolar septal 
thickness and fewer numbers of alveolar macrophages and other inflammatory cells (D, F ). Magnification × 400.BMC Cancer 2005, 5:59 http://www.biomedcentral.com/1471-2407/5/59
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which steadily increased from 3–14 weeks. The temporal
increase with XRT-TG was less steep than XRT-WT (XRT-
WT vs. XRT-TG, at 3, 6, 10 and 14 weeks, p < 0.05, Figure
6a) (Representative images of XRT-WT vs. XRT-TG at 3
and 14 weeks after irradiation shown in Figure 7C–F).
In XRT-WT mice, there was significant increase in p-
Smad2/3 positivity by 3 weeks post irradiation (XRT-WT
vs. XRT-TG, at 3, 6, 10 and 14 weeks, p < 0.05, Figure 6b).
With time, the fraction of positively staining cells also
increased in XRT-TG animals but this p-Smad2/3 expres-
sion was significantly diminished when compared with
XRT-WT. Thus, RT not only increased TGFβ  expression
and activation, but also increased signal transduction
down the fibrosis pathway. This effect was significantly
attenuated by over-expression of ECSOD. (Representative
images of XRT-WT vs. XRT-TG at 3 and 14 weeks after irra-
diation shown in Figure 7G–J).
Comparison of TGFβ 1 activation in irradiated lung tissue Figure 5
Comparison of TGFβ 1 activation in irradiated lung tissue. Increase active TGFβ 1 expression began by 1 week. By 6 weeks, 
there was significantly more activated TGFβ 1 in the lungs of XRT-WT mice (grey squares) vs. XRT-TG animals (grey triangles) 
(XRT-WT vs. XRT-TG, at 6, 10 and 14 wks, # p < 0.05). There were significantly more total TGFβ 1 levels in XRT-WT (black 
squares) vs. XRT-TG animals (black triangles) at late time points (XRT-WT vs. XRT-TG, at 10 and 14 wks, * p < 0.05). Error 
bars represent 95% confidence intervals.
0
2
4
6
8
10
12
0
0.2
0.4
0.6
0.8
1
C o n t r o l 1 D1 W3 W6 W 1 0 W 1 4 W
XRT-WT
XRT-TG
XRT-WT
XRT-TG
T
o
t
a
l
 
T
G
F
-
E

(
n
g
/
m
l
)
A
c
t
i
v
e
 
T
G
F
-
E

(
n
g
/
m
l
)
Time (D=Day, W=Week)
Total TGFE
Active TGFE

*
*

BMC Cancer 2005, 5:59 http://www.biomedcentral.com/1471-2407/5/59
Page 9 of 13
(page number not for citation purposes)
a): Smad3 expression after irradiation Figure 6
a): Smad3 expression after irradiation. Cells expressing Smad3 were counted at 40X magnification in four random fields by 
two blinded observers. The Smad3 positive cell count for each animal was the mean of all eight readings. Increased expression 
of Smad3 in XRT-WT lungs was noticeable at 1 wk, and which steadily increased from 3–14 wks. This temporal increase in 
XRT-TG was significantly reduced than XRT-WT (XRT-WT vs. XRT-TG, at 3, 6, 10 and14 wks, * p < 0.05). b): p-Smad2/3 
expression after irradiation. For p-Smad2/3, cell positivity was counted at 40X and mean value for each animal was taken. 
In XRT-WT lung, there was significant increase in p-Smad2/3 expression by 3 weeks post irradiation. With time, the fraction of 
positively staining cells also increased in XRT-TG animals but the level of expression in this group was significantly decreased 
when compared with XRT-WT (XRT-WT vs. XRT-TG, at 3, 6, 10 and 14 wks, * p < 0.05). Error bars represent 95% confi-
dence intervals.
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Representative images of Smad3 immunohistochemistry  Figure 7
Representative images of Smad3 immunohistochemistry of controls (A, B ) and XRT-WT vs. XRT-TG groups at 3 wk (C, D ) and 
14 wks (E, F ). For Smad3, most positively stained cells are present in damaged areas of XRT-WT lungs, which showed signifi-
cantly increased cell positivity when compared with XRT-TG animals. Representative images of p-Smad2/3 immunohistochem-
istry of XRT-WT vs. XRT-TG groups at 3 wk (G, H ) and 14 wks (I, J ) after irradiation. XRT-WT animals exhibited 
significantly increased positivity for p-Smad2/3 when compared with XRT-TG mice. See the results section for the details. Mag-
nification × 400.BMC Cancer 2005, 5:59 http://www.biomedcentral.com/1471-2407/5/59
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Discussion
The current evidence indicates that acute RT-induced
damage to the lung is characterized by inflammatory
changes, which proceed to the development of fibrotic
lesions in the late phase. Ultimately, complete structural
ablation will ensue, if the source of inflammatory/fibro-
genic mediators and oxidative stress is not removed or
attenuated [13]. Our data demonstrate that
overexpression of ECSOD in mouse lung appears to con-
fer protection from acute RT damage by reducing the
inflammatory response, decreasing in TGFβ 1 activation
and, consequently, downregulation of TGFβ  signal trans-
duction pathway.
Prior work by our laboratory has revealed that EC-SOD is
protective against chronic RT-induced lung injury, but we
were unable to differentiate between the acute phase
inflammatory response (pneumonitis /alveolitis) and the
fibrotic response to pulmonary irradiation because only a
single late time point was studied [13]. To begin to answer
this question, we used TG mice in which alveolar and air-
way epithelial cells overexpress EC-SOD. Thus, by using
this TG mouse model we were able to enhance the antioxi-
dant capacity of the extracellular pulmonary compart-
ment in which antioxidant reserves may play critical roles
in preserving pulmonary function against early RT
damage.
The lung is among one of the most radiosensitive viscera
to ionizing RT. Ionizing RT has long been recognized to
induce an inflammatory response within irradiated tis-
sues [18-22]. Strong evidence implicates a key role for
inflammation in the development of radiation induced
pulmonary injury [23]. Suppression of this acute inflam-
mation may lead to a reduction in subsequent fibrosis.
The mechanism underlying the inflammatory response in
RT-induced lung injury is complex. Endothelial damage
leads to leukocyte adhesion and transmigration into tis-
sues. Inflammatory cells are a known source of ROS
[24,25]. These cells can also release inflammatory and
fibrogenic cytokines [26], which further contribute to
injury in part through the recruitment of more inflamma-
tory cells to the site of injury [5]. The time course for
recruitment of the inflammatory cells in the lower respira-
tory tract of XRT-WT animals in this study demonstrates
the important role of inflammation in early radiation
injury. In the presence of a potent anti-inflammatory
stimulus, i.e., EC-SOD, XRT-TG animals suffered signifi-
cantly less RT-induced pulmonary damage.
The anti-inflammatory effects of EC-SOD also appear to
reduce the risk of subsequent fibrosis. The elevated levels
of EC-SOD in transgenic mice has been shown to be pro-
tective against the development of pulmonary fibrosis
from a number of stimuli, including RT, hyperoxia and
bleomycin induced pulmonary fibrosis [13-15]. EC-SOD
TG mice have been shown to better tolerate hyperoxia, in
part by reducing the excessive influx of inflammatory cells
into the lung [15]. In a mouse model of influenza virus-
induced pneumonia, the overexpression of EC-SOD
markedly ameliorated the inflammatory and oxidant
responses in the lung [27]. This protective effect of EC-
SOD was attributed to inhibitory action against a series of
inflammatory mediators. Similar effects were also noticed
after exogenous administration of SOD's [28,29] in influ-
enza- induced lung injury.
In contrast to EC-SOD overexpressing animals, EC-SOD
knockout mice have shown evidence for increased sensi-
tivity to hyperoxia exposure, which was exhibited by ear-
lier onset of inflammatory reactions and interstitial
edema, when compared with wild-type mice [30]. In
another study, EC-SOD null mice demonstrated increased
susceptibility to inflammation and pulmonary fibrosis.
From these results the authors proposed that one mecha-
nism by which EC-SOD protects against pulmonary fibro-
sis is by inhibiting inflammation [31]. This appears to be
the case following radiation as well.
One of the means by which EC-SOD appears to reduce
pulmonary inflammation is through suppressing activa-
tion and recruitment of macrophages. Macrophages
increase in number shortly after irradiation and have been
shown to produce a broad spectrum of cytokines, which
stimulate fibroblast proliferation and the production of
an extracellular matrix [32]. These include platelet-
derived growth factor (PDGF) [33], interleukin-1 (IL-1)
[34], tumor necrosis factor α  (TNFα ) [35], basic fibroblast
growth factor (bFGF) [36], and TGFβ  [37]. These
cytokines not only regulate fibroblast function and
collagen synthesis, but also recruit other inflammatory
cells and contribute to the pathogenesis of both acute and
late RT damage [38]. The macrophage count of XRT-TG
mice in this study at different time points revealed a sig-
nificant reduction when compared with XRT-WT. This
observation supports the notion that the protective effect
of EC-SOD is mediated, at least in part, by its ability to
attenuate the influx of macrophages.
Several lines of evidence have supported the use of thera-
peutic strategies targeting TGFβ 1 to prevent
fibroproliferative disorders of various organs [3]. Due to
its implication in lung fibrogenesis, blockade of the TGFβ
pathway has been proposed as a molecular strategy to
ameliorate pulmonary fibrosis and is therefore of poten-
tial clinical significance [39]. Using a soluble version of
TGFβ  type II receptor, Wang et al [40] found that pulmo-
nary fibrosis, including excess collagen accumulation, was
greatly reduced in hamsters after bleomycin administra-BMC Cancer 2005, 5:59 http://www.biomedcentral.com/1471-2407/5/59
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tion. Similarly, we found that soluble TGFβ  type II recep-
tor gene therapy led to a significant reduction of acute RT-
induced lung injury in rats 4 weeks after irradiation [41].
Interference with the TGFβ  signal transduction pathway
has also been shown to protect against fibrosis formation.
Recently, Smad7, an intracellular antagonist of TGFβ  sig-
naling, has been shown to attenuate bleomycin-induced
lung fibrosis in mice receiving intratracheal injection of
recombinant adenovirus overexpressing Smad7 [42].
Smad3 knockout mice have been shown to be protected
from RT-induced soft tissue injury [43]. This loss of
Smad3 interfered with the chemotactic response of neu-
trophils, macrophages, keratinocytes, and fibroblasts to
TGFβ  [44-47]. Upregulation of TGFβ  at sites of injury was
also Smad3 dependent [43].
Our data further support the notion that TGFβ 1 signaling
through the Smad 3 pathway is critical to the develop-
ment of RT-induced injury. Overexpression of EC-SOD
leads to downregulation of this signaling pathway as evi-
denced by both reduced expression and phosphorylation
of Smad3. Inhibition of Smad3, or even partial reduction
in its activity might afford protection against the toxicities
of irradiation. Taken together, these results suggest that
abrogation of TGFβ  signaling might be sufficient to offer
protection against lung fibrogenesis.
In summary, this study shows that overexpression of EC-
SOD confers protection against RT induced acute lung
injury. EC-SOD appears to work, in part, via an attenua-
tion of the macrophage response. In addition, sustained
EC-SOD expression decreases TGFβ  activation with a sub-
sequent downregulation of the profibrotic TGF-β  path-
way. Thus, EC-SOD in the extracellular compartments of
the lung is an important modulator of the complex
response of normal tissue to acute radiation insult.
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